HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleaved carbon minibeams: an experimental radiosurgery method with clinical potential.

AbstractPURPOSE:
To evaluate the efficacy of "interleaved carbon minibeams" for ablating a 6.5-mm target in a rabbit brain with little damage to the surrounding brain. The method is based on the well-established tissue-sparing effect of arrays of thin planes of radiation.
METHODS AND MATERIALS:
Broad carbon beams from the National Aeronautics and Space Agency Space Radiation Facility at Brookhaven National Laboratory were segmented into arrays of parallel, horizontal, 0.3-mm-thick planar beams (minibeams). The minibeams' gradual broadening in tissues resulted in 0.525-mm beam thickness at the target's proximal side in the spread-out Bragg peak. Interleaving was therefore implemented by choosing a 1.05 mm beam spacing on-center. The anesthetized rabbit, positioned vertically on a stage capable of rotating about a vertical axis, was exposed to arrays from four 90° angles, with the stage moving up by 0.525 mm in between. This produced a solid radiation field at the target while exposing the nontargeted tissues to single minibeam arrays. The target "physical" absorbed dose was 40.2 Gy.
RESULTS:
The rabbit behaved normally during the 6-month observation period. Contrast magnetic resonance imaging and hematoxylin and eosin histology at 6 months showed substantial focal target damage with little damage to the surrounding brain.
CONCLUSION:
We plan to evaluate the method's therapeutic efficacy by comparing it with broad-beam carbon therapy in animal models. The method's merits would combine those of carbon therapy (i.e., tight target dose because of the carbon's Bragg-peak, sharp dose falloff, and high relative biological effectiveness at the target), together with the method's low impact on the nontargeted tissues. The method's smaller impact on the nontargeted brain might allow carbon therapy at higher target doses and/or lower normal tissue impact, thus leading to a more effective treatment of radioresistant tumors. It should also make the method more amenable to administration in either a single dose fraction or in a small number of fractions.
AuthorsF Avraham Dilmanian, Adam Rusek, Giovanna R Fois, John Olschowka, Nicolle R Desnoyers, Jane Y Park, Istvan Dioszegi, Bari Dane, Ruiliang Wang, Dardo Tomasi, Hedok Lee, Sean D Hurley, Patricia K Coyle, Allen G Meek, M Kerry O'Banion
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 84 Issue 2 Pg. 514-9 (Oct 01 2012) ISSN: 1879-355X [Electronic] United States
PMID22342299 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Carbon
Topics
  • Animals
  • Behavior, Animal (radiation effects)
  • Brain (pathology, radiation effects)
  • Brain Neoplasms (pathology, surgery)
  • Carbon (therapeutic use)
  • Magnetic Resonance Imaging
  • Monte Carlo Method
  • Organs at Risk (radiation effects)
  • Patient Positioning (methods)
  • Rabbits
  • Radiation Injuries, Experimental (prevention & control)
  • Radiosurgery (methods)
  • Radiotherapy Dosage
  • Relative Biological Effectiveness

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: